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The intracutaneous injection of killed suspensions of Hemophilus ducreyi was
shown by Ito (1) to produce a focal reaction of induration and hyperemia in
human patients with chancroidal infection. This finding led to the employment
of such vaccines for diagnostic purposes. Although opinions have varied as to
the sensitivity and specificity of this test, Ducrey antigens have been extensively
employed, especially in foreign countries, as diagnostic aids, and they have
been generally recognized to be of value (2, 3, 4).
In this country in the past, diagnostic antigens have been successfully pre-
pared from organisms cultivated in media containing liquid defibrinated rabbit
blood (5, 6). In the preparation of the vaccine, lysis of red blood cells and re-
moval of hemoglobin could be accomplished by washing the bacterial suspen-
sions several times in sterile distilled water. However, the final product contained
rabbit red cell debris, in addition to the bacilli.
Beeson et at. (7) reported that a medium containing serum or ascitic fluid
would support the growth of this organism. Later, Deacon et at. (8) confirmed
the results of these workers, and found that rabbit serum could be substituted
for whole blood in cultivation of H. ducreyi. Feiner et at. (9) reported that rab-
bits infected by the intradermal injection of living Ducrey bacilli subsequently
developed cutaneous sensitivity to the inoculation of heat killed organisms.
These workers employed both commercial vaccine (Lederle) and their own
antigens and found that previously injected animals reacted in a manner similar
to man. The homemade preparations were made from organisms grown in
serum broth.
Until recently a commercially prepared antigen (Lederle) was available for
use in this country. This company has ceased to manufacture the vaccine, and
until such time as commercial products are again available, prospective users
of Ducrey antigens will have to employ homemade preparations.
The purpose of this communication is to report the results of a study in which
rabbits were employed to test the potency of various vaccines prepared in our
laboratory. These antigens were made from both virulent and avirulent strains
of H. ducreyi cultivated in a liquid medium enriched with rabbit serum.
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MATERIALS AND METHODS
Rabbits: A total of 18 Albino and New Zealand White rabbits of mixed sex
were used in this study. On the basis of past history and age, the animals were
divided into three groups. Group I consisted of 6 rabbits that had previously
been infected by intradermal inoculations of cultures and by rubbing cultures
into scarified areas of skin (10). Three months after all lesions had completely
healed, these rabbits were utilized in this study. Group II consisted of 6 young,
previously non-infected rabbits, weighing 2.0 kilos or less. Group III consisted of
6 old previously non-infected rabbits, weighing 3.6 kilos or over. Each animal
was kept in an individual cage, and fed antibiotic-free rabbit pellets. All animals
were housed in an air-conditioned room, at a temperature of 72°F.
Preparation of vaccines: Four sLrains of H. ducreyi, two virulent and two avirulent, were
selected for preparation of antigens. A single strain was employed for the production of each
vaccine. The two avirulent organisms were designated as HD 11 and HD 16. They were old
stock cultures that had lost their ability to infected humans in the manner described by
Greenblatt (11). In addition, they had lost their ability to infect rabbits by intradermal
inoculation. The two virulent strains were designated as CilIA and 212.
For preparation of vaccines, each strain of H. ducreyi was cultivated in a medium con-
taining rabbit serum in place of whole blood (12). This medium was prepared in the follow-
ing manner: 5 grams of Bacto-casetone was dissolved in 1 liter of physiological saline. This
mixture was autoclaved for 15 minutes. Sterile rabbit serum was then added to make a
final concentration of 7.5 per cent serum. This liquid medium was dispensed in 200 nil.
amounts in sterile 250 ml. screw cap bottles and kept in a mechanical refrigerator at 5°C.
until used.
Seventy-two hour old colonies that had been grown on the surface of blood agar plates
in the manner outlined by Deacon et al. (8) were used to seed the medium described above.
Colonies from the surface of a plate were carefully picked off with a wire loop, inoculated
into separate bottles, and incubated for 24 hours at 37°C. At this time good growth of all
4 strains was obtained. A check for contamination was made and no contaminants were
isolated.
The 24 hour growth of each strain was transferred to a separate 250 ml. sterile centrifuge
tube, and the contents sedimentated by high speed centrifugation. The supernatant fluid
was discarded, and the sediment resuspended in 200 ml. of sterile distilled water and again
spun down. The organisms were washed in this fashion a total of three times. Then, the
washed sediment, consisting of bacilli, was suspended in 200 ml. of sterile physiological
saline, placed in 250 ml. screw cap bottles, and heated in a water bath for 30 minutes at
60°C. After heating, formalin, serving as a preservative, was added to make a final con-
centration of 0.3 per cent. The stock antigens were then kept in a refrigerator at 5°C. until
used.
For use on the rabbits in this study, each of the four vaccines, were then prepared, on
the basis of density, in five concentrations. This was accomplished in the following manner:
A Coleman, Model 9, Nephocolorimeter* was employed to determine the density of com-
mercial Ducrey antigen (Lederle). This antigen was determined to have a density of 300
Coleman units. The lowest concentration of each of the four vaccines was adjusted to the
approximate density of the commercial product. Then four higher concentrations of each
vaccine were prepared to equal 5, 10, 50, and 100 times, respectively, the density of the
commercia1 product. The antigens were then stored in a mechanical refrigerator at 5°C.
until used.
Inoculation of rabbits: The abdomen of each rabbit was clipped and shaved.
* Coleman Instruments Co., Maywood, Illinois.
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All antigens were injected intradermally in 0.2 ml. amounts in this site. Inocula-
tions were made with a 25 gauge needle fitted to the hub of a 1 ml. tuberculin
syringe. A separate syringe and needle was used for each antigen administered.
Each rabbit was observed daily for a period of one week, and size and appear-
ance of reactions were recorded. Size of induration was measured with vernier
calipers.
RESULTS
As shown in Table I, there was a marked difference in cutaneous response of
previously infected and non-infected rabbits to the inoculation of vaccines.
After 48 hours, all previously infected animals developed at the sites of inocula-
tion focal areas of induration and erythema which measured at least 7 mm. in
diameter. Where higher concentrations of antigens were employed, the reac-
tions were of slightly greater diameter. These reactions persisted for as long as
72 hours, after which time they gradually subsided. By the end of one week
they disappeared. No evidence of tissue breakdown could be detected in any
case.
In the previously non-infected animals (Group II and Group III), after 48
hours, in some cases evidence of slight induration could be detected at the sites
where higher concentrations of antigens were injected. However, these papules
were pale in appearance and never exceeded 3 mm. in size. By 72 hours, they
commenced to subside, and by the end of one week they disappeared.
Reference to Table I will show no apparent difference in results between
rabbits in Group II and Group III. Young, previously non-infected animals
responded to the injection of vaccines in the same manner as did the old previ-
ously non-infected rabbits.
The results of this study showed no qualitative or quantitative difference in
antigenicity of any of the strains of H. ducreyi employed for production of
vaccines. The virulence of the strain did not appear to affect the reactions in
any way.
DISCUSSION AND CONCLUSIONS
This study has again demonstrated the possibility of preparing diagnostic
antigens from organisms cultivated in a medium containing rabbit serum in
place of whole blood. Such vaccines have the advantage of being free of rabbit
red cell debris. However, this is not intended to imply that presence of red cell
debris would affect the diagnostic value of antigens for human use.
Dienst (6) reported that vaccines employed on human cases were equally
effective, whether prepared from virulent or avirulent strains of H. dvcreyi.
This study has demonstrated the same to hold true for rabbits. We could not
detect any qualitative or quantitative difference in antigenicity of any of the
strains of H. ducreyi employed for vaccine production.
The density of the vaccines did not materially affect the reactions produced
in previously infected rabbits. The vaccines of higher concentration produced
reactions of only slightly greater diameter in such animals. However, in previ-
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ously non-infected rabbits, in some cases papules of 3 mm. or less in size and
pale in appearance did develop where the higher concentrations were employed.
Therefore, to avoid difficulties in interpretation of results in rabbits, it would
appear that vaccines with a density of 300 to 1500 Coleman units are preferable.
This study again points to the possibility of utilizing rabbits for assaying
potency of Ducrey skin test antigens. Also, as pointed out by Feiner et al. (9),
the possibility exists that the rabbit may be employed to investigate the basic
mechanism by which cutaneous sensitivity develops following infection with
H. ducreyi.
SUMMARY
1. Vaccines were prepared from 4 strains of H. ducreyi (2 virulent and 2
avirulent) cultivated in a medium containing rabbit serum in place of whole
blood.
2. The intracutaneous inoculation of killed suspensions of H. ducreyi was
shown to produce focal reactions of induration and hyperemia in previously
infected rabbits.
3. No qualitative or quantitative differences in antigenicity could be detected
in vaccines prepared from virulent or avirulent strains of H. ducreyi.
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